ALGS · Aligos Therapeutics, Inc.
$4.34
+0.09 (+2.12%)
At close · Jul 30
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“our recurring losses from operations and negative cash flows have raised substantial doubt regarding our ability to continue as a going concern”View the 10-Q filed May 7, 2026
Market Cap
$15.25M
Shares
3.59M
Aligos Therapeutics, Inc. Earnings Call Transcripts
Every quarterly earnings call for Aligos Therapeutics, Inc. (ALGS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
No Earnings Calls Available
No earnings call events are available for this stock yet.